Perfluoroalkyl substances and changes in bone mineral density: A prospective analysis in the POUNDS-LOST study

Published on Dec 1, 2019in Environmental Research5.026
· DOI :10.1016/j.envres.2019.108775
Yang Hu11
Estimated H-index: 11
(Harvard University),
Gang Liu (HUST: Huazhong University of Science and Technology)+ 8 AuthorsQi Sun62
Estimated H-index: 62
(Harvard University)
Abstract Background Recent studies suggested an inverse association between exposures to perfluoroalkyl substances (PFASs) and bone mineral density (BMD). Whether exposures to PFASs are also associated with changes in BMD has not been examined. Methods Five major PFASs (perfluorooctanesulfonic acid, PFOS; perfluorooctanoic acid, PFOA; perfluorohexanesulfonic acid, PFHxS; perfluorononanoic acid, PFNA; perfluorodecanoic acid, PFDA) and BMD (g/cm2) at six bone sites (spine, total hip, femoral neck, hip intertrochanteric area, hip trochanter, and hip Ward's triangle area) were measured at baseline among 294 participants in the POUNDS-LOST study, a weight-loss trial, of whom a total of 175 participants had BMD measured at both baseline and year 2. Linear regression was used to model the differences or changes in BMD for each SD increment of PFAS concentrations. In a secondary analysis, interactions between PFASs and baseline body mass index (BMI), as well as a BMI-related genetic risk score (GRS) derived from 97 BMI-predicting SNPs were examined in relation to changes in BMD. Results At baseline, both PFOS and PFOA were significantly associated with lower BMD at several sites. For each SD increase of PFOS, the βs (95% CIs) for BMD were −0.020(-0.037, −0.003) for spine, −0.013(-0.026, 0.001) for total hip, −0.014(-0.028, 0.000) for femoral neck, and −0.013(-0.026, 0.000) for hip trochanter. For PFOA, the corresponding figures were −0.021(-0.038, −0.004) for spine, −0.015(-0.029, −0.001) for total hip, and −0.015(-0.029, −0.002) for femoral neck. After adjusting for baseline covariates and 2-year weight change, higher baseline plasma concentrations of PFOS, PFNA, and PFDA were associated with greater reduction in BMD in the hip; the βs (95% CIs) were −0.005(-0.009, −0.001), −0.006(-0.010, −0.001), and −0.005(-0.009, −0.001), respectively. Similar associations were found in hip intertrochanteric area for all PFASs except PFHxS, with βs ranging from −0.006 for PFOA to −0.008 for PFOS and PFNA. Participants with a higher GRS tended to have less PFAS-related BMD decline in total hip (Pinteraction = 0.005) and the hip intertrochanteric area (Pinteraction = 0.021). There were similar PFAS-related BMD changes by baseline BMI levels, although the interactions did not achieve statistical significance. Conclusions This study demonstrated that higher plasma PFAS concentrations were not only associated with a lower BMD at baseline, but also a faster BMD loss in a weight-loss trial setting. Genetic predisposition to larger body size may somewhat attenuate the deleterious effects of PFASs on BMD. Further exploration of the possible impact of PFAS exposures on bone density is warranted.
  • References (46)
  • Citations (1)
📖 Papers frequently viewed together
1 Citations
2 Citations
14 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
#1Dimitrios Agas (University of Camerino)H-Index: 14
#2Giovanna Lacava (University of Camerino)H-Index: 2
Last. Maria Giovanna Sabbieti (University of Camerino)H-Index: 18
view all 3 authors...
3 CitationsSource
#1Gang Liu (Harvard University)H-Index: 18
#2Klodian Dhana (Harvard University)H-Index: 17
Last. Qi Sun (Harvard University)H-Index: 62
view all 12 authors...
Background The potential endocrine-disrupting effects of perfluoroalkyl substances (PFASs) have been demonstrated in animal studies, but whether PFASs may interfere with body weight regulation in humans is largely unknown. This study aimed to examine the associations of PFAS exposure with changes in body weight and resting metabolic rate (RMR) in a diet-induced weight-loss setting. Methods and findings In the 2-year POUNDS Lost randomized clinical trial based in Boston, Massachusetts, and Baton ...
23 CitationsSource
#1Gloria B. Post (New Jersey Department of Environmental Protection)H-Index: 8
#2Jessie A. Gleason (New Jersey Department of Health and Senior Services)H-Index: 7
Last. Keith R. Cooper (RU: Rutgers University)H-Index: 25
view all 3 authors...
Perfluoroalkyl acids (PFAAs), a group of synthetic organic chemicals with industrial and commercial uses, are of current concern because of increasing awareness of their presence in drinking water and their potential to cause adverse health effects. PFAAs are distinctive among persistent, bioaccumulative, and toxic (PBT) contaminants because they are water soluble and do not break down in the environment. This commentary discusses scientific and risk assessment issues that impact the development...
19 CitationsSource
#1John P. Kemp (UoB: University of Bristol)H-Index: 43
#2John A. Morris (McGill University)H-Index: 10
Last. David Evans (UoB: University of Bristol)H-Index: 90
view all 38 authors...
Osteoporosis is a common disease diagnosed primarily by measurement of bone mineral density (BMD). We undertook a genomewide association study (GWAS) in 142,487 individuals from the UK Biobank to identify loci associated with BMD as estimated by quantitative ultrasound of the heel. We identified 307 conditionally independent single-nucleotide polymorphisms (SNPs) that attained genome-wide significance at 203 loci, explaining approximately 12% of the phenotypic variance. These included 153 previo...
97 CitationsSource
#1Antti Koskela (University of Oulu)H-Index: 11
#2Jani Koponen (National Institute for Health and Welfare)H-Index: 9
Last. Juha Tuukkanen (University of Oulu)H-Index: 35
view all 6 authors...
Perfluoroalkyl substances (PFAS), including two most commonly studied compounds perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA), are widely distributed environmental pollutants, used extensively earlier. Due to their toxicological effects the use of PFAS is now regulated. Based on earlier studies on PFOA’s distribution in bone and bone marrow in mice, we investigated PFAS levels and their possible link to bone microarchitecture of human femoral bone samples (n = 18). Soft tiss...
9 CitationsSource
#1Yoriko Heianza (Tulane University)H-Index: 19
#2Wenjie Ma (Harvard University)H-Index: 9
Last. Lu QiH-Index: 73
view all 9 authors...
OBJECTIVE Fibroblast growth factor 21 (FGF21) is involved in the regulation of energy balance and adipose metabolism. Our previous genome-wide association study identified genetic variants in the FGF21 region associated with macronutrient intake preference. We investigated whether the FGF21 genotype modified effects of weight-loss diets varying in macronutrient intake on changes in adiposity in a 2-year randomized diet intervention trial. RESEARCH DESIGN AND METHODS We genotyped FGF21 rs838147 i...
22 CitationsSource
Background:Perfluoroalkyl acids (PFASs) are suspected thyroid toxicants, but results from epidemiological studies are inconsistent.Objectives:We examined associations between serum PFASs and thyroi...
25 CitationsSource
#1Naila Khalil (Wright State University)H-Index: 11
#2Aimin Chen (UC: University of Cincinnati)H-Index: 32
Last. Kurunthachalam Kannan (University at Albany, SUNY)H-Index: 104
view all 7 authors...
Background Perfluoroalkyl substances (PFASs), including perfluorooctanoic acid (PFOA), perfluorooctane sulfonic acid (PFOS), perfluorohexane sulfonic acid (PFHxS), and perfluorononanoic acid (PFNA), are detectable in the serum of 95% of the U.S. population. Objective Considering the role of PFASs as endocrine disruptors, we examined their relationships with bone health. Methods The association between serum PFAS concentration and bone mineral density at total femur (TFBMD), femoral neck (FNBMD),...
27 CitationsSource
#1Petra Henning (University of Gothenburg)H-Index: 21
#2H. Herschel Conaway (University of Arkansas for Medical Sciences)H-Index: 14
Last. Ulf H. Lerner (Umeå University)H-Index: 46
view all 3 authors...
Vitamin A (retinol) is a necessary and important constituent of the body which is provided by food intake of retinyl esters and carotenoids. Vitamin A is known best for being important for vision, but in addition to the eye, vitamin A is necessary in numerous other organs in the body, including the skeleton. Vitamin A is converted to an active compound, all-trans-retinoic acid (ATRA), which is responsible for most of its biological actions. ATRA binds to intracellular nuclear receptors called re...
25 CitationsSource
#1Adam E. Locke (UM: University of Michigan)H-Index: 25
#2Bratati Kahali (UM: University of Michigan)H-Index: 14
Last. Elizabeth K. Speliotes (UM: University of Michigan)H-Index: 27
view all 482 authors...
Obesity is heritable and predisposes to many diseases. To understand the genetic basis of obesity better, here we conduct a genome-wide association study and Metabochip meta-analysis of body mass index (BMI), a measure commonly used to define obesity and assess adiposity, in up to 339,224 individuals. This analysis identifies 97 BMI-associated loci (P 20% of BMI variation. Pathway analyses provide strong support for a role of the central nervous system in obesity susceptibility and implicate new...
1,783 CitationsSource
Cited By1
#1Riann Jenay Egusquiza (UCI: University of California, Irvine)
#2Bruce Blumberg (UCI: University of California, Irvine)H-Index: 66
The incidence of obesity has reached an all-time high and this increase is observed worldwide. There is a growing need to understand all of the factors that contribute to obesity in order to effectively treat and prevent it and associated comorbidities. The obesogen hypothesis proposes that there are chemicals in our environment termed "obesogens" that can impact individual susceptibility to obesity and thus help explain the recent large increases in obesity. This review discusses current advanc...